The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II "ICH-ADAPT II"


Phase 2 Results N/A

Summary of Purpose

The vast majority of intracerebral hemorrhage (ICH) patients present with elevated blood pressure(BP). Management of BP is controversial with two competing rationales. There is some evidence that hyperacute treatment may improve outcomes by reducing the rate of hematoma expansion. Physicians have been reluctant to reduce BP early after ICH onset, fearing reduced cerebral blood flow (CBF) will increase ischemia...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 4 April 2018.

1 Nov 2012 29 Oct 2014 1 Dec 2018 Unavailable 1 Apr 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment